Research and publications — the complete index

By Hemant K. Rohera — ORCID 0009-0005-3275-1743
Published 20 September 2026 · Last updated 20 October 2026

This is the whole record, and each item carries the label it actually deserves: granted patents, journal articles, preprints, technical notes, and datasets and code. Preprints and technical notes are not peer-reviewed, and this page says so rather than leaving it to be discovered.

Download the whole list for a reference manager: publications.bib (BibTeX). The same record is on ORCID, which is the authoritative list.

Granted patents

The three families are granted in further jurisdictions; every grant, by number and country, is in the patent register.

Journal article indexed in PubMed

The venue, described accurately: Cureus is a Springer Nature title and this review is indexed in PubMed via PMC. It is not MEDLINE-indexed and not Scopus-indexed.

Manuscripts under peer review

Submitted and under review. None has been accepted, and none should be cited as published.

Preprints and working papers

Deposited on Zenodo (CERN) under CC BY 4.0 with the ORCID iD attached. A preprint is a dated public record, not peer review. Each DOI below is the concept DOI and always opens the latest version.

1. Rohera HK. Two Stores, One Power Pack: Battery–Supercapacitor Hybrid Storage and the Patented Hybrid Power Pack. A Consolidated Scientific Monograph on the Physics, Architecture, Control, Battery Management, Sizing, Safety, Standards and Evidence. Zenodo; 2026. Monograph (preprint), version 1.0. doi 10.5281/zenodo.23021957.
   Copy on figshare: 10.6084/m9.figshare.34025316.
2. Rohera HK. Two Stores, One Power Pack: The Physics of Battery–Supercapacitor Hybridisation, the Patented Hybrid Power Pack Architecture, and the Applications Where It Delivers Most. Zenodo; 2026. Preprint, version 1.1. doi 10.5281/zenodo.22958076.
   Copy on figshare: 10.6084/m9.figshare.34004445.
3. Rohera HK. The Hybrid Power Pack as a Platform: Balancing, Protection and Multi-Source Charging. A Claim-by-Claim Engineering Analysis of US 10,523,019 B2. Zenodo; 2026. Preprint, version 1.2. doi 10.5281/zenodo.22970638.
   Copy on figshare: 10.6084/m9.figshare.34004421. Under peer review at a journal.
4. Rohera HK. Sizing Supercapacitors for Minimum Weight Across Twelve Applications: End-of-Life Design, Self-Discharge, Heat and Life, Sensitivity, Converters and Standards. Zenodo; 2026. Preprint, version 1.0. doi 10.5281/zenodo.23301485.
   Under peer review at a journal.
5. Rohera HK. Bioelectrical Parameters of Living Systems: A Scientific Framework for Understanding Voltage, Current, Frequency and Biological Function. Zenodo; 2026. Preprint, version 1.3.0. doi 10.5281/zenodo.22829923.
6. Rohera HK. Electrical Properties of Human Tissues and Cells: From Membrane Potential to Systemic Electrophysiology. Zenodo; 2026. Preprint, version 1.12. doi 10.5281/zenodo.22827987.
7. Rohera HK. A Review of Physical-Energy Approaches to Therapeutic Modulation: Electrical, Electromagnetic, Optical, Acoustic and Thermal Modalities Compared on Dose. Zenodo; 2026. Preprint, version 1.7. doi 10.5281/zenodo.22827989.
8. Rohera HK. Reporting and Classifying Bioelectric Claims: A Minimum Parameter Set and an Evidence Classification for Studies Applying Electrical Energy to Tissue. Zenodo; 2026. Preprint, version 0.3.3. doi 10.5281/zenodo.23043340.
9. Rohera HK. Voltage, current and frequency parameters in bioelectric therapeutic devices: a scoping review of the design space. Zenodo; 2026. Preprint, version 1.2. doi 10.5281/zenodo.22718287.
   Also posted on Research Square: 10.21203/rs.3.rs-11167527/v1.
10. Rohera HK. The Electrical Body: what membrane voltage does, what applied current can and cannot do, and where eMedica's Voltage–Current–Frequency therapy sits in the evidence. Zenodo; 2026. Preprint, version 1.2. doi 10.5281/zenodo.22719203.
11. Rohera HK. Reporting standards for claims about bioelectronic and energy-storage devices: denominators, scope statements, and the arithmetic of a zero. Zenodo; 2026. Preprint, version 1.0. doi 10.5281/zenodo.22828647.
12. Rohera HK. Controlled Electromagnetic and Electrical Stimulation of the Agricultural Root Zone: A Testable Framework for Investigating Plant Growth, Stress Responses and Crop Protection. Zenodo; 2026. Working paper, version 1.0. doi 10.5281/zenodo.22829811.

Full texts with figures and references are also published on this site: Two Stores, One Power Pack, The Hybrid Power Pack as a Platform, the consolidated monograph and The Electrical Body.

Technical notes

Short open-access notes on Zenodo, typed on the record as technical notes. Two of them exist to say that something does not work: CO₂ utilisation is an energy carrier rather than a source, and a static magnetic field does no work on a stationary conductor.

Datasets and code

The scripts re-run every calculation in the Hybrid Power Pack papers.

Other journal articles (co-authored, 2022–2026)

Listed for completeness, as published. These venues have not passed, or have not yet been put through, the five-point check below, and none of these articles is cited as evidence anywhere on this site. A citation is a record of what was published, not a claim about a device: nothing on this site presents any device as a treatment for a named condition.

1. Singh RK, Reddy H, Nagpal D, Girdhar A, Apsara A, Rohera H. eMedica—Electromagnetic Cell Current Modulation Approach in the Management of Oral Health Complications in Diabetes Mellitus. International Journal of Drug Delivery Technology 2026; 16(27s). doi 10.25258/ijddt.16.27s.113.
2. Rohera H, Nagpal D. Controlled Voltage, Current, Frequency (VCF) Application for Accelerating Chronic Wound Healing and Angiogenesis. Journal of Applied Bioanalysis 2025; 11(6). doi 10.53555/jab.v11i6.836.
3. Nagpal D, Rohera H, Jambhulkar M. Electromagnetic Cell Current Modulation via eMedica for Oral Health Improvement in HIV-Positive Patients: A Pilot Study on Lesion Resolution, Salivary Immunity, and Quality of Life. International Journal of Environmental Sciences 2025; article page.
   The DOI printed by the journal (10.64252/q49yft92) did not resolve when checked on 20 October 2026.
4. Rohera H, Nagpal DJ. Evaluating the efficacy of microcurrent infusion technology through eMedica in the management of gout: An analysis of patient outcomes. Indian Journal of Medical Sciences 2025; 78:80–84. doi 10.25259/ijms_287_2024.
5. Dongre SB, Foujdar AI, Rohera H, Bagde L, Dhengar Y, Nagpal D. The Clinical and Biophysical Impacts of Voltage-Current-Frequency (VCF) Therapy Using the eMedica Device in Orthopedic Healing. Journal of Neonatal Surgery 2025; article page.
   No DOI.
6. Pagare V, Hande PS, Rohera H, Nagpal D. Optimization of Cellular Frequencies in Therapeutic Interventions for Varicose Veins using eMedica: A Pilot Study. Frontiers in Health Informatics 2024; article page.
   No DOI.
7. Rohera H, Apte GM, Apte MV, Nagpal D. A review of electromagnetic frequency modulation, with a focus on eMedica as a therapeutic approach for Parkinson's disease, that goes beyond pharmaceutical treatments. Frontiers in Health Informatics 2024; article page.
   No DOI.
8. Rajashekar K, Patil H, Rohera H, Chouhan R, Nagpal D. Use of Electron Therapy Device eMedica in the Management of Chronic Lymphocytic Leukemia: A case report. Frontiers in Health Informatics 2024; article page.
   No DOI.
9. Reddy BS, Khatri V, Begum GS, Rohera H, Chouhan R, Nagpal D. Therapeutic Potential of eMedica's Electron-Driven Cell Therapy in Treating Cancer: Addressing Fundamental Aspects of Cellular Physiology. South Eastern European Journal of Public Health 2024; pp. 2569–2573. doi 10.70135/seejph.vi.2493.
10. Nagpal D, Rohera H. Evaluating the Efficacy of E-medica: A Cross-Sectional Analysis of Its Role in Hypertension Management. African Journal of Biomedical Research 2024; 27(1s). article page.
    The DOI printed by the journal (10.53555/ajbr.v27i1s.1721) did not resolve when checked on 20 October 2026. Venue discontinued in Scopus (estate check, 13 September 2026).
11. Hande PS, Rohera H, Begum GS, Nagpal D, Gowda S, Goud BKM. Enhancing Patient Outcomes with eMedica Technology in the Fight Against COVID-19: A Health and Medicine Approach. African Journal of Biomedical Research 2024; 27(1S):2861–2878. doi 10.53555/ajbr.v27i1s.1919.
    Venue discontinued in Scopus (estate check, 13 September 2026).
12. Rohera H. Emedica: A Noninvasive Device to Improve Insulin Sensitivity in Type 2 Diabetes Patients. Revista Electronica de Veterinaria 2024; 25(1):2469–2473. doi 10.69980/redvet.v25i1.1256.
13. Rohera H. eMedica: A Potentially Groundbreaking Device for the Optimization of Cellular Frequencies in Therapeutic Interventions — An Overview of Current Research. Journal of Population Therapeutics and Clinical Pharmacology 2022; pp. 1913–1917. doi 10.53555/6pxabh32.
    Venue discontinued in Scopus (estate check, 13 September 2026).
14. Rohera H. Advancements in Disease Treatment through Optimizing Cellular Energy with eMedica Therapy. European Chemical Bulletin 2022; 11(9):1644–1651. doi 10.53555/ecb.v11:i9.17740.

The check every venue has to pass

Before a journal is cited, submitted to, or named as evidence anywhere in this estate, five things are checked. All five, every time.

1. Scopus status now, and status at the date of the paper.
2. DOAJ listing, current.
3. MEDLINE indexing — and “in PubMed via PMC” is not MEDLINE indexing.
4. Does the DOI resolve, and to the publisher of record for that ISSN?
5. Absence from the hijacked-journal registers.

For a repository or a preprint server the honest statement is that points 1 to 3 do not apply.

How to cite this work

Cite the DOI, not this page. Each DOI resolves through doi.org to the record of record. For the author identifier, use the ORCID iD 0009-0005-3275-1743. The patent record spells the name three ways — why that is.

Where the profiles are

How this list is counted. One entry per work: versions and mirror copies (figshare, Research Square) are noted under the work, not counted again. Totals: 42 items, plus 3 manuscripts under review.